Insulet to Present at Upcoming Investor Conferences

Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology, will present at two virtual investor conferences. The Canaccord 41st Annual Growth Conference is scheduled for August 11, 2021, at 11:00 a.m. ET, followed by the UBS Genomics 2.0 and MedTech Innovations Summit on August 12, 2021, at 4:00 p.m. ET. Live audio webcasts can be accessed via investors.insulet.com, with replays available post-event. Insulet is dedicated to enhancing diabetes management through its innovative Omnipod Insulin Management System.

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod^® brand of products, today announced that management will present at two upcoming virtual investor conferences:

• The Canaccord 41^st Annual Growth Conference on Wednesday, August 11, 2021 at 11:00 a.m. (Eastern Time)
• The UBS Genomics 2.0 and MedTech Innovations Summit on Thursday, August 12, 2021 at 4:00 p.m. (Eastern Time)

To listen to the live audio webcast of the presentation, please visit investors.insulet.com. A replay of the audio webcast will also be available following the event.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: insulet.com and omnipod.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210726005023/en/

FAQ

What are the dates for Insulet's presentations at investor conferences?

Insulet Corporation will present at the Canaccord 41st Annual Growth Conference on August 11, 2021, and at the UBS Genomics 2.0 and MedTech Innovations Summit on August 12, 2021.

How can I listen to Insulet's conference presentations?

You can listen to the live audio webcasts of Insulet's presentations by visiting investors.insulet.com.

What is the Omnipod product platform by Insulet Corporation?

The Omnipod product platform is an innovative Insulin Management System that provides a tubeless alternative for insulin delivery.

What time will Insulet’s presentations start at the investor conferences?

The Canaccord conference presentation will start at 11:00 a.m. ET and the UBS conference presentation at 4:00 p.m. ET.

Where is Insulet Corporation headquartered?

Insulet Corporation is headquartered in Massachusetts.